Investing in the digital future of healthcare.
PCD CareHub is building a European buy-and-build platform in healthcare technology. Scalable market demand, manageable risk, and compliance built in from day one.
- Buy-and-build
- European
- ESG-responsible
This page is informational and does not constitute investment advice, an offer, or an invitation to make an investment decision. For deal flow, investment memos, and confidential portfolio information, we engage exclusively following a personal introduction and — where appropriate — on the basis of an NDA.
Three pillars underlying the thesis
Market demand
Buy-and-build logic
European scale
- TAM digital healthcare Europe
- Statista, 2024. Definition: software, platforms, telehealth, and digital health services in the EU27+UK. Figure represents the projected market in 2030 based on bottom-up segmentation.
- EU healthcare expenditure as % of GDP
- Eurostat, 2024 — Health expenditure statistics (SHA 2011). Rolling multi-year average across EU27. Rising due to aging populations and chronic care.
- Market growth health technology
- Precedence Research, 2024 — Digital Health Market Report. CAGR projection 2024–2034 globally; cumulative growth translated to index.
- 75+ population Netherlands 2040
- CBS, Core Projection 2024–2070. Share of 75+ in total population; middle scenario.
Figures are indicative and intended to provide market context — they do not represent revenue, return, or valuation expectations for PCD CareHub. For full methodology, definitions, and scenario analysis, we refer to the original publications and — for confidential deal flow — to our investor memo following NDA execution.
Four steps from acquisition to value creation.
Identify
Systematic screening of European health tech companies for product-market fit, team, and culture.
Acquire
Transparent deal structures with founder-friendly rollover and earn-out arrangements where appropriate.
Integrate
Technical integration into the CareHub layer and operational synergy without sacrificing product focus.
Scale
Shared go-to-market and capital access for international expansion.
Selective, transparent, and engaged
We are building a concentrated portfolio within healthcare technology — not a bundle of unrelated software assets. Deal flow, thesis, and due diligence are shared confidentially with onboarded partners.
Thesis-driven
Active ownership
Long-term horizon
From first contact to data room.
Introduction
30 minutes, no pitch. We listen first — you set the pace.
NDA
Upon signing, we confidentially share our investment memo and current deal flow.
Management call
In-depth conversation with the founding team on thesis, portfolio, and structure.
Data room
Due diligence access for qualified parties. No open application process.
ESG is not an appendix.
We report as standard on impact across care quality, staff well-being, data sovereignty, and the climate footprint of our infrastructure.
- SFDR Art. 8
- EU Taxonomy
- CSRD-ready
People who have built this market before
The PCD team combines deep operational healthcare experience with buy-and-build expertise from the software industry. Visit the leadership page to learn more about each individual.
Insights for investors & partners
The market outlook we invest behind: ecosystem strategy, governance, and the European healthcare transition.
Buy-and-build in healthcare tech: what works and what doesn't
Three lessons from five years of buy-and-build platform strategy in European healthcare tech: what works for consolidation, founder retention, and compliance synergy.
Read article
Samen voor Gezondheid 2026: signals for health tech
At the 'Samen voor Gezondheid, Zorg en Welzijn' congress, a clear message emerged: digitalization, interoperability, and the call for a national EHR.
Read article
Why AI in Healthcare Requires Trust
AI in healthcare succeeds or fails on trust. What trustworthy AI concretely means for care providers, patients, and healthcare organizations in the Netherlands.
Read article
Ready to explore the thesis in greater depth?
We share deal flow and investment memos only following a personal introduction.